Source:http://linkedlifedata.com/resource/pubmed/id/19208589
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2009-3-16
|
pubmed:abstractText |
A CD30-CD153 mast cell axis has been described in skin inflammations and Hodgkin's lymphoma. We investigated if a soluble form of CD153 is present in the serum and synovial fluid (SF) of patients with rheumatoid arthritis (RA), and determined whether mast cells express CD153 in the synovium of these patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0315-162X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
501-7
|
pubmed:meshHeading |
pubmed-meshheading:19208589-Antigens, CD30,
pubmed-meshheading:19208589-Arthritis, Rheumatoid,
pubmed-meshheading:19208589-CD30 Ligand,
pubmed-meshheading:19208589-Case-Control Studies,
pubmed-meshheading:19208589-Humans,
pubmed-meshheading:19208589-Mast Cells,
pubmed-meshheading:19208589-Synovial Fluid
|
pubmed:year |
2009
|
pubmed:articleTitle |
CD153 in rheumatoid arthritis: detection of a soluble form in serum and synovial fluid, and expression by mast cells in the rheumatic synovium.
|
pubmed:affiliation |
Department of Medicine, Karolinska Institutet, KS-L2:04, 171 76 Stockholm, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|